Tag Archive | "big biotech"

BioMarin acquires Prosensa for up to $840 million

Tags: , ,


BioMarin Pharmaceutical and Prosensa Holding have entered into a definitive agreement in which BioMarin will offer to purchase all of the outstanding ordinary shares of Prosensa for $17.75 per share, for a total up front consideration of approximately $680 million Read the full story

Qiagen and Astellas form a biotech partnership to develop companion diagnostics

Tags: , , ,


QIAGEN announced a biotech partnership agreement with Astellas Pharma to develop and commercialize companion diagnostics paired with Astellas drugs for use in cancer and other diseases. Read the full story

Janssen signs a biotech deal with Ruijin Hospital

Tags: , ,


Janssen Pharma signed a biotech deal to collaborate on translational research with Shanghai Ruijin Hospital, which opened a Translational Medicine Center in early October. Read the full story

Molecular Devices and Roche form a biotech partnership for Nano-TRF assay

Tags: , , ,


Molecular Devices has partnered with the Discovery Technologies team at the Roche announced a biotech partnership to develop a high-throughput detection system for drug discovery screens employing Roche's proprietary Ruthenium-based nanosecond time resolved fluorescence (Nano-TRF) assays. Read the full story

CSL has acquired the Flu vaccine business from Novartis

Tags: , , ,


Novartis announced has entered an agreement that CSL has acquired its influenza vaccine business in a $275 million deal that will require regulatory approval before it closes by the end of the second half of 2015. Read the full story

Medivation has signed a exclusive pharma licensing deal with CureTech

Tags: , , , ,


Medivation has signed pharma licensing deal for exclusive worldwide rights to CureTech's late-stage clinical molecule pidilizumab (CT-011), an immune modulatory anti-PD-1 monoclonal antibody. Read the full story

Ipsen and Lexicon signs pharma licensing deal

Tags: , , , ,


Ipsen and Lexicon Pharmaceuticals have entered into an exclusive pharma licensing deal for Ipsen to commercialize telotristat etiprate outside of North America and Japan, with a focus on the treatment of carcinoid syndrome. Read the full story

NewLink Genetics strike $1 billion pharma deal with Genentech

Tags: , ,


NewLink Genetics has inked a pharma deal potentially worth $1 billion with Genentech for the development of NLG919, NewLink's IDO pathway inhibitor. Read the full story

Morphosys acquires lanthipeptide technology from Lanthio Pharma

Tags: , , , ,


MorphoSys and Lanthio Pharma acquires of Lanthio Pharma's lanthipeptide technology, which will be used for drug discovery by MorphoSys. Read the full story

Current Agreements Deal Analysis Update : October 2014

Tags: , , , ,


This month we provide you with an overview of deal analysis in the life science sectors, covering partnering, M&A and financing in September 2014. Read the full story